Report from Annual General Meeting in SyntheticMR AB (publ)
Igår, 19:19
Report from Annual General Meeting in SyntheticMR AB (publ)
The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 27, 2026, whereby the meeting resolved in accordance with the Nomination Committee and Board's proposed resolutions. The full resolutions are stated in the notice of the meeting.
The following resolutions were made at the AGM:
The AGM resolved to approve the Board's proposal that no dividend will be paid. The remaining capitalized funds of SEK 83,334,137 including the share premium reserve and retained earnings, are transferred in new accounts.
The AGM resolved to grant the Board of directors and CEO’s discharge.
The AGM decided that the Board should consist of 4 ordinary members and no deputies. The AGM resolved on the re-election of Board members Johanna Fälting, Gisli Hennermark, Ann-Christine Sundell and Staffan Persson. Further, the AGM decided to elect Gisli Hennermark as the Chairman of the Board.
The AGM resolved that a Nomination Committee should be appointed by the Annual General Meeting instructing the Chairman of the Board to contact the three largest shareholders (hereby both direct registered shareholders and nominee-registered shareholders) in accordance with Euroclear Sweden AB's printout of the share register as of September 30, 2026.
For additional information, please contact Lena Åredal, CEO, SyntheticMR AB, +46 76 770 99 08, lena.aredal@syntheticmr.com
Ämnen i artikeln
Report from Annual General Meeting in SyntheticMR AB (publ)
Igår, 19:19
Report from Annual General Meeting in SyntheticMR AB (publ)
The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 27, 2026, whereby the meeting resolved in accordance with the Nomination Committee and Board's proposed resolutions. The full resolutions are stated in the notice of the meeting.
The following resolutions were made at the AGM:
The AGM resolved to approve the Board's proposal that no dividend will be paid. The remaining capitalized funds of SEK 83,334,137 including the share premium reserve and retained earnings, are transferred in new accounts.
The AGM resolved to grant the Board of directors and CEO’s discharge.
The AGM decided that the Board should consist of 4 ordinary members and no deputies. The AGM resolved on the re-election of Board members Johanna Fälting, Gisli Hennermark, Ann-Christine Sundell and Staffan Persson. Further, the AGM decided to elect Gisli Hennermark as the Chairman of the Board.
The AGM resolved that a Nomination Committee should be appointed by the Annual General Meeting instructing the Chairman of the Board to contact the three largest shareholders (hereby both direct registered shareholders and nominee-registered shareholders) in accordance with Euroclear Sweden AB's printout of the share register as of September 30, 2026.
For additional information, please contact Lena Åredal, CEO, SyntheticMR AB, +46 76 770 99 08, lena.aredal@syntheticmr.com
Ämnen i artikeln
Analys
Valet 2026
Analys
Valet 2026
Marknadsöversikt
1 DAG %
Senast
1 mån
